$149 Million is the total value of ISZO CAPITAL MANAGEMENT LP's 12 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TARO | Sell | TARO PHARMACEUTICALS INDUS LTD | $90,011,000 | -17.1% | 582,409 | -23.4% | 60.33% | -2.1% |
| UHAL | Buy | AMERCO | $16,777,000 | +6.0% | 43,074 | +7.1% | 11.24% | +25.2% |
| NATH | Buy | NATHANS FAMOUS INC NEW | $14,595,000 | +200.3% | 283,063 | +121.5% | 9.78% | +254.6% |
| CSWI | New | CSW INDUSTRIALS INC | $8,052,000 | – | 213,761 | +100.0% | 5.40% | – |
| FUR | Sell | WINTHROP RLTY TRsh ben int new | $6,094,000 | -41.7% | 469,821 | -35.5% | 4.08% | -31.2% |
| UPIP | Buy | UNWIRED PLANET INC NEW | $3,567,000 | +148.7% | 4,133,615 | +108.9% | 2.39% | +193.7% |
| MMAC | Buy | MMA CAP MGMT LLC | $3,014,000 | +610.8% | 208,579 | +542.5% | 2.02% | +738.2% |
| HTCH | New | HUTCHINSON TECHNOLOGIES INC | $2,890,000 | – | 805,000 | +100.0% | 1.94% | – |
| QLTI | New | QLT INC | $2,135,000 | – | 802,600 | +100.0% | 1.43% | – |
| YOKU | New | YOUKU TUDOU INCsponsored adr | $1,357,000 | – | 50,000 | +100.0% | 0.91% | – |
| PCO | New | PENDRELL CORP | $698,000 | – | 1,393,753 | +100.0% | 0.47% | – |
| ANAD | New | ANADIGICS INC | $1,000 | – | 84 | +100.0% | 0.00% | – |
| TTPH | Exit | TETRAPHASE PHARMACEUTICALS I | $0 | – | -12,000 | -100.0% | -0.05% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -17,000 | -100.0% | -0.78% | – |
| LAKE | Exit | LAKELAND INDS INC | $0 | – | -253,300 | -100.0% | -2.00% | – |
| SURG | Exit | SYNERGETICS USA INC | $0 | – | -833,883 | -100.0% | -3.11% | – |
| CSWC | Exit | CAPITAL SOUTHWEST CORP | $0 | – | -509,137 | -100.0% | -13.70% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NAM TAI PPTY INC | 16 | Q3 2022 | 60.5% |
| AVID BIOSERVICES INC | 13 | Q4 2021 | 46.6% |
| XPEL INC | 10 | Q4 2021 | 22.3% |
| TARO PHARMACEUTICALS INDUS LTD | 8 | Q4 2015 | 85.7% |
| AMERCO | 8 | Q4 2015 | 11.2% |
| NATHANS FAMOUS INC NEW | 7 | Q1 2017 | 68.9% |
| MMA CAP MGMT LLC | 7 | Q1 2017 | 17.8% |
| CBL & ASSOC PPTYS INC | 6 | Q3 2023 | 95.2% |
| LIFECORE BIOMEDICAL INC | 6 | Q4 2022 | 35.1% |
| CRYO-CELL INTL INC | 6 | Q4 2022 | 11.0% |
View ISZO CAPITAL MANAGEMENT LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View ISZO CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.